Patents by Inventor Dennis Sustarsic

Dennis Sustarsic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the detection of endometriosis using an ME-2 antigen
    Patent number: 8030007
    Abstract: A method for diagnosing endometriosis in a human subject comprising the steps of detecting a test amount of an antibody that specifically binds to SEQ ID NO: 6 polypeptide or a truncated peptide comprising an epitope of SEQ ID NO: 6 in a sample from the subject; and comparing the test amount with a normal range of the antibody in a control sample from a subject who does not suffer from endometriosis, whereby a test amount above the normal range provides a positive indication in the diagnosis of endometriosis.
    Type: Grant
    Filed: March 3, 2011
    Date of Patent: October 4, 2011
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: A. Said El Shami, Bruce Campbell, Dennis Sustarsic, Niver Sahakian
  • METHOD FOR THE DETECTION OF ENDOMETRIOSIS USING AN ME-2 ANTIGEN
    Publication number: 20110201129
    Abstract: A method for diagnosing endometriosis in a human subject comprising the steps of detecting a test amount of an antibody that specifically binds to SEQ ID NO: 6 polypeptide or a truncated peptide comprising an epitope of SEQ ID NO: 6 in a sample from the subject; and comparing the test amount with a normal range of the antibody in a control sample from a subject who does not suffer from endometriosis, whereby a test amount above the normal range provides a positive indication in the diagnosis of endometriosis.
    Type: Application
    Filed: March 3, 2011
    Publication date: August 18, 2011
    Inventors: A. Said El Shami, Bruce Campbell, Dennis Sustarsic, Niver Sahakian
  • Method of detecting endometriosis in human subjects using SEQ ID No. 9 or an epitope thereof
    Patent number: 7981626
    Abstract: A method for diagnosing endometriosis in a human subject comprising the steps of detecting a test amount of an antibody that specifically binds to SEQ ID NO:9 polypeptide or a truncated peptide comprising an epitope of SEQ ID NO: 9, in a sample from the subject; and comparing the test amount with a normal range of the antibody in a control sample from a subject who does not suffer from endometriosis, whereby a test amount above the normal range provides a positive indication in the diagnosis of endometriosis.
    Type: Grant
    Filed: July 22, 2009
    Date of Patent: July 19, 2011
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: A Said El Shami, Bruce Campbell, Dennis Sustarsic, Niver Sahakian
  • Methods of diagnosing endometriosis in human subjects using the ME-5 polypeptide
    Patent number: 7879562
    Abstract: A method for diagnosing endometriosis in a human subject comprising the steps of detecting a test amount of an antibody that specifically binds to ME-5 (SEQ ID NO:3) polypeptide or a peptide comprising an epitope of ME-5 in a sample from the subject; and comparing the test amount with a normal range of the antibody in a control sample from a subject who does not suffer from endometriosis, whereby a test amount above the normal range provides a positive indication in the diagnosis of endometriosis.
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: February 1, 2011
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: A. Said El Shami, Bruce Campbell, Dennis Sustarsic, Niver Sahakian
  • Method of diagnosing endometriosis in human subjects
    Publication number: 20100330696
    Abstract: A method for diagnosing endometriosis in a human subject comprising the steps of detecting a test amount of an antibody that specifically binds to EPP2 (SEQ ID NO:9) polypeptide or a peptide comprising an epitope of EPP2 in a sample from the subject; and comparing the test amount with a normal range of the antibody in a control sample from a subject who does not suffer from endometriosis, whereby a test amount above the normal range provides a positive indication in the diagnosis of endometriosis.
    Type: Application
    Filed: July 22, 2009
    Publication date: December 30, 2010
    Inventors: A Said El Shami, Bruce Campbell, Dennis Sustarsic, Niver Sahakian
  • Method of diagnosing endometriosis in human subjects
    Publication number: 20100062453
    Abstract: A method for diagnosing endometriosis in a human subject comprising the steps of detecting a test amount of an antibody that specifically binds to ME-5 (SEQ ID NO:3) polypeptide or a peptide comprising an epitope of ME-5 in a sample from the subject; and comparing the test amount with a normal range of the antibody in a control sample from a subject who does not suffer from endometriosis, whereby a test amount above the normal range provides a positive indication in the diagnosis of endometriosis.
    Type: Application
    Filed: July 15, 2009
    Publication date: March 11, 2010
    Inventors: A. Said El Shami, Bruce Campbell, Dennis Sustarsic, Niver Sahakian
  • ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
    Publication number: 20080153106
    Abstract: Three human endometrial antigens, ME-5, ME-2 and EPP2, and combination thereof have been discovered that are the targets of antibodies present in the serum of women suffering from endometriosis. These protein products and the human antibodies reactive with them are used as tools for diagnostic assays that monitor patients with the disease of endometriosis.
    Type: Application
    Filed: November 6, 2006
    Publication date: June 26, 2008
    Inventors: A. Said El Shami, Bruce Campbell, Dennis Sustarsic, Niver Sahakian
  • ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
    Publication number: 20070178528
    Abstract: Three human endometrial antigens, ME-5, ME-2 and EPP2, and combination thereof have been discovered that are the targets of antibodies present in the serum of women suffering from endometriosis. These protein products and the human antibodies reactive with them are used as tools for diagnostic assays that monitor patients with the disease of endometriosis.
    Type: Application
    Filed: November 6, 2006
    Publication date: August 2, 2007
    Inventors: A.Said Shami, Bruce Campbell, Dennis Sustarsic, Niver Sahakian
  • ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
    Publication number: 20070141600
    Abstract: Three human endometrial antigens, ME-5, ME-2 and EPP2, and combination thereof have been discovered that are the targets of antibodies present in the serum of women suffering from endometriosis. These protein products and the human antibodies reactive with them are used as tools for diagnostic assays that monitor patients with the disease of endometriosis.
    Type: Application
    Filed: November 6, 2006
    Publication date: June 21, 2007
    Inventors: A. Said Shami, Bruce Campbell, Dennis Sustarsic, Niver Sahakian
  • ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
    Publication number: 20060008876
    Abstract: Three human endometrial antigens, ME-5, ME-2 and EPP2, and combination thereof have been discovered that are the targets of antibodies present in the serum of women suffering from endometriosis. These protein products and the human antibodies reactive with them are used as tools for diagnostic assays that monitor patients with the disease of endometriosis.
    Type: Application
    Filed: July 7, 2004
    Publication date: January 12, 2006
    Inventors: A. Shami, Bruce Campbell, Dennis Sustarsic, Niver Sahakian